Atlas Trials

A Double-blind and Randomized Trial of Celecoxib Added to Risperidone in Treatment-naive First-episode Schizophrenia

Clinical trial NCT00686140 · COMPLETED

Trial details

NCT number
NCT00686140
Sponsor
Beijing HuiLongGuan Hospital
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Schizophrenia
Start date
2006-06-01
Primary completion
2007-12-01
Enrollment
200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.